<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cancer - Ovarian on VitaminDWiki</title><link>//localhost:1313/categories/cancer---ovarian.html</link><description>Recent content in Cancer - Ovarian on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Fri, 17 May 2024 00:00:00 +0000</lastBuildDate><atom:link href="//localhost:1313/categories/cancer---ovarian/index.xml" rel="self" type="application/rss+xml"/><item><title>Risk of Ovarian Cancer reduced 27% for each 8 ng increase in Vitamin D</title><link>//localhost:1313/posts/risk-of-ovarian-cancer-reduced-27-percent-for-each-8-ng-increase-in-vitamin-d.html</link><pubDate>Fri, 17 May 2024 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/risk-of-ovarian-cancer-reduced-27-percent-for-each-8-ng-increase-in-vitamin-d.html</guid><description>&lt;h4 id="predicted-25-hydroxyvitamin-d-over-the-adult-life-and-the-risk-of-ovarian-cancer">Predicted 25-hydroxyvitamin D over the adult life and the risk of ovarian cancer&lt;/h4>
&lt;p>Am J Epidemiol. 2024 May 17:kwae070. &lt;a href="https://doi.org/10.1093/aje/kwae070">doi: 10.1093/aje/kwae070&lt;/a> PDF behind paywall&lt;/p>
&lt;p>Jennifer A Ritonja 1 2 3 4, Coraline Danieli 5 6, Magnoudewa Priscille Pana 1, Michael J Palmer 1, Kevin L&amp;rsquo;EspÃ©rance 1 2, Vikki Ho 1 2, Michal Abrahamowicz 5 6, Anita Koushik 1 2 3 4&lt;/p>
&lt;p>The evidence from previous studies of serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> and ovarian cancer risk are not conclusive. However, 25(OH)D was generally only measured in late adulthood, which may not capture the etiologically relevant exposure periods. We investigated predicted 25(OH)D over the adult lifetime in relation to ovarian cancer risk in a population-based case-control study conducted from 2011 to 2016 in Montreal, Canada (490 cases, 896 controls). Predicted 25(OH)D was computed using previously validated regression models. Unconditional multivariable logistic regression models were used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for average predicted 25(OH)D over the adult life and risk. In addition, the relative importance of different periods of past 25(OH)D exposure was explored using a weighted cumulative exposure (WCE) model.&lt;/p></description></item><item><title>Gynecological cancers and atherosclerosis (perhaps a Vitamin D association)</title><link>//localhost:1313/posts/gynecological-cancers-and-atherosclerosis-perhaps-a-vitamin-d-association.html</link><pubDate>Mon, 29 Jan 2024 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/gynecological-cancers-and-atherosclerosis-perhaps-a-vitamin-d-association.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#correlation-between-gynecological-tumors-and-atherosclerotic-diseases">Correlation between gynecological tumors and atherosclerotic diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#recommendation-take-vitamin-d-to-reduce-the-risk-of-cancers-atherosclerosis-and-many-other-health-problems">Recommendation: Take Vitamin D to reduce the risk of cancers, atherosclerosis, and many other health problems&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="correlation-between-gynecological-tumors-and-atherosclerotic-diseases">Correlation between gynecological tumors and atherosclerotic diseases&lt;/h4>
&lt;p>Arch Med Sci Atheroscler Dis. 2023 Dec 30:8:e118-e122. &lt;a href="https://doi.org/10.5114/amsad/176655">doi: 10.5114/amsad/176655&lt;/a>&lt;/p>
&lt;p>Francesk Mulita 1, Vasileios Leivaditis 2, Platon Dimopoulos 3, Artemis Ibra 1, Fotios Iliopoulos 4, Konstantinos Tasios 1, Christos Pitros 5, Charalampos Kaplanis 1, Angelis Peteinaris 6, Konstantinos Bouchagier 1, Spyros Papadoulas 5, Michail Pitiakoudis 7&lt;/p></description></item></channel></rss>